Foreign Affairs

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

· 22 July 2026 · 2 min read
0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Hindustan Times has reported a new India-focused foreign affairs development: “0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines.” The publisher's feed describes the story as follows: In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. Intellectual Janata Party includes this item for public-affairs discovery and context only; readers should use the o

Original reporting by Hindustan TimesRead the full story

Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.

#foreign-affairs#india

Related reading

IJP
News Brief
Foreign secretary Vikram Misri flags tariff move in talks with US undersecretary
Foreign Affairs·The Economic Times·25 Sep 2026

Foreign secretary Vikram Misri flags tariff move in talks with US undersecretary

Read full story →
IJP
News Brief
India and the plausible multilateralism of BRICS
Foreign Affairs·The Hindu·25 Sep 2026

India and the plausible multilateralism of BRICS

Read full story →
IJP
News Brief
CEA flags US friction, energy shocks, and missing AI play as India’s key near-term risks
Foreign Affairs·Mint·25 Sep 2026

CEA flags US friction, energy shocks, and missing AI play as India’s key near-term risks

Read full story →
IJP
News Brief
India, 17 others reserve rights to join Russia’s CBAM dispute with EU as third party at WTO
Foreign Affairs·The Economic Times·25 Sep 2026

India, 17 others reserve rights to join Russia’s CBAM dispute with EU as third party at WTO

Read full story →